LANCET CHILD & ADOLESCENT HEALTH, ISSN 2352-4642, 11/2019, Volume 3, Issue 11, pp. 769 - 780
Background Antenatal corticosteroids given to women before preterm birth improve infant survival and health. However, whether dexamethasone or betamethasone...
MORTALITY | ANTENATAL CORTICOSTEROIDS | COUNTRIES | WEIGHT INFANTS | INCOME | PEDIATRICS | OUTCOMES | CARE | CHILDREN | AGE
MORTALITY | ANTENATAL CORTICOSTEROIDS | COUNTRIES | WEIGHT INFANTS | INCOME | PEDIATRICS | OUTCOMES | CARE | CHILDREN | AGE
Journal Article
Ultrasound in Obstetrics and Gynecology, ISSN 0960-7692, 2019
Journal Article
The Lancet Neurology, ISSN 1474-4422, 07/2019, Volume 18, Issue 7, pp. 643 - 652
Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared...
MICROBLEEDS | SUPERFICIAL SIDEROSIS | SIGNS | AMYLOID ANGIOPATHY | ACUTE ISCHEMIC-STROKE | ANTITHROMBOTIC THERAPY | ASPIRIN | CLINICAL NEUROLOGY | Atrophy | Neuroimaging | Anticoagulants | Stroke | Aspirin | Statistical analysis | Medical imaging | Magnetic resonance imaging | Computed tomography | Biomarkers | Hemorrhage
MICROBLEEDS | SUPERFICIAL SIDEROSIS | SIGNS | AMYLOID ANGIOPATHY | ACUTE ISCHEMIC-STROKE | ANTITHROMBOTIC THERAPY | ASPIRIN | CLINICAL NEUROLOGY | Atrophy | Neuroimaging | Anticoagulants | Stroke | Aspirin | Statistical analysis | Medical imaging | Magnetic resonance imaging | Computed tomography | Biomarkers | Hemorrhage
Journal Article
The Lancet, ISSN 0140-6736, 06/2019, Volume 393, Issue 10191, pp. 2613 - 2623
Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial...
DEFINITIONS | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | RESUMPTION | EVENTS | ANTITHROMBOTIC THERAPY | GUIDELINES | PREVENTION | ASPIRIN | INTRACRANIAL HEMORRHAGE | Anticoagulants | Therapy | Stroke | Heart attacks | Embolisms | Health risks | Risk | Systematic review | Hazards | Regression analysis | Patients | Hemorrhage | Thrombosis | Optimization | Disease prevention | Prevention | Randomization | Vascular diseases | Collaboration
DEFINITIONS | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | RESUMPTION | EVENTS | ANTITHROMBOTIC THERAPY | GUIDELINES | PREVENTION | ASPIRIN | INTRACRANIAL HEMORRHAGE | Anticoagulants | Therapy | Stroke | Heart attacks | Embolisms | Health risks | Risk | Systematic review | Hazards | Regression analysis | Patients | Hemorrhage | Thrombosis | Optimization | Disease prevention | Prevention | Randomization | Vascular diseases | Collaboration
Journal Article
Trials, ISSN 1745-6215, 03/2018, Volume 19, Issue 1, pp. 162 - 11
Background: For adults surviving stroke due to spontaneous (non-traumatic) intracerebral haemorrhage (ICH) who had taken an antithrombotic (i.e. anticoagulant...
Antiplatelet therapy | Secondary prevention | Stroke | Intracerebral haemorrhage | Randomised controlled trial | MEDICINE, RESEARCH & EXPERIMENTAL | RECRUITMENT | TELEPHONE | METAANALYSIS | EVENTS | LOW-DOSE ASPIRIN | DISEASE | Cerebral Hemorrhage - chemically induced | Disability Evaluation | Drug Administration Schedule | Stroke - diagnostic imaging | Humans | Risk Factors | Treatment Outcome | United Kingdom | Cerebral Hemorrhage - physiopathology | Cerebral Hemorrhage - diagnostic imaging | Stroke - physiopathology | Randomized Controlled Trials as Topic | Fibrinolytic Agents - adverse effects | Magnetic Resonance Imaging | Multicenter Studies as Topic | Stroke - chemically induced | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Cerebral Hemorrhage - therapy | Fibrinolytic Agents - administration & dosage | Stroke - therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke (Disease) | Care and treatment | Algorithms | Anticoagulants (Medicine) | Comparative analysis | Health aspects | Intracerebral hemorrhage
Antiplatelet therapy | Secondary prevention | Stroke | Intracerebral haemorrhage | Randomised controlled trial | MEDICINE, RESEARCH & EXPERIMENTAL | RECRUITMENT | TELEPHONE | METAANALYSIS | EVENTS | LOW-DOSE ASPIRIN | DISEASE | Cerebral Hemorrhage - chemically induced | Disability Evaluation | Drug Administration Schedule | Stroke - diagnostic imaging | Humans | Risk Factors | Treatment Outcome | United Kingdom | Cerebral Hemorrhage - physiopathology | Cerebral Hemorrhage - diagnostic imaging | Stroke - physiopathology | Randomized Controlled Trials as Topic | Fibrinolytic Agents - adverse effects | Magnetic Resonance Imaging | Multicenter Studies as Topic | Stroke - chemically induced | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Cerebral Hemorrhage - therapy | Fibrinolytic Agents - administration & dosage | Stroke - therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke (Disease) | Care and treatment | Algorithms | Anticoagulants (Medicine) | Comparative analysis | Health aspects | Intracerebral hemorrhage
Journal Article